About Nueclear
Nueclear is a Healthcare company based in Mumbai (India) founded in 2013. Network of PET-CT and CT scan centers providing cancer diagnostic services. Nueclear has raised $4 million across 1 funding round from investors including Norwest Venture Partners. Its chief executive, as recorded, is Rahul Guha. Its Indian entity Nueclear Healthcare Limited reported revenue of ₹49.49 Cr. Nueclear offers products and services including PET-CT Scan and CT Scan. Its focus areas include Clinical Laboratories and Radiology.
Company details
Founded in 2013 in Mumbai, India, Nueclear operates as a network of diagnostic centers focused on cancer imaging. Services encompass various PET-CT scans, plain and contrast CT scans, and production of required radioactive biomarkers using advanced technologies. Appointments are scheduled, reports delivered via in-person, email, or courier methods, and payments processed online. Operations emphasize early detection and monitoring through affordable solutions in the healthcare sector.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website nueclear.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Nueclear Healthcare Limited
- Date of Incorporation 31 Jan, 2011
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹49.49 Cr
FY 2026 · -3% YoY
- Net Profit₹6.16 Cr
FY 2026 · 12% margin
- EBITDA₹11.03 Cr
FY 2026 · 22% margin
- Total Equity Funding$4M (USD)
in 1 rounds
- Latest Funding Round$4M (USD), Series A
Jan 2013
- Investors
Associated legal entities of Nueclear
Nueclear operates through Nueclear Healthcare Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nueclear Healthcare Limited CIN U74120MH2011PLC212839 | Active | 31 Jan 2011 | Navi Mumbai, Maharashtra | ₹49.5 Cr | 7 | View details |
Products & Services of Nueclear
Nueclear offers a comprehensive portfolio of products and services, including PET-CT Scan and CT Scan.
PET-CT scans are provided for cancer detection, staging, and monitoring using fusion imaging that combines functional and anatomical aspects
CT scans are offered for plain and contrast imaging to diagnose a broad spectrum of ailments
Apps and channels of Nueclear
its YouTube channel Nueclear Healthcare Limited has 63 subscribers.
Funding Insights of Nueclear
Nueclear has successfully raised a total of $4M through 1 strategic funding round. The most recent funding activity was a Series A round of $4 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4M
- Total Rounds 1
- Last Round Series A — $4M
- First Round $4M
(Jan 2013)
- Investors Count 1
All 1 funding rounds of Nueclear with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $4M | Series A | – | – |
1 investors in total: 1 institutional.
Investors in Nueclear
Nueclear has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Norwest Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors. | 1961 | nvp.com | Menlo Park, United States |
Investor details for Nueclear
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Nueclear Healthcare Limited (Nueclear)
Nueclear Healthcare Limited is the primary company behind Nueclear. The board of Nueclear Healthcare Limited currently have 5 directors; the longest-serving is Rahul Franklin Guha, appointed in 2022. 27 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Franklin Guha DIN 09588432 | Director | 04 May 2022 | 4 yrs 6 mo | Nueclear Healthcare Limited |
| Prapti Ishwar Gilada DIN 07125024 | Director | 01 Aug 2023 | 3 yrs 3 mo | Nueclear Healthcare Limited |
| Alok Kumar Jagnani DIN 00644360 | Director | 14 May 2024 | 2 yrs 5 mo | Nueclear Healthcare Limited |
| Nishant Amilal Shah DIN 09025935 | Director | 23 Jul 2024 | 2 yrs 3 mo | Nueclear Healthcare Limited |
| Anandh Sundar DIN 10409065 | Director | 23 Jul 2024 | 2 yrs 3 mo | Nueclear Healthcare Limited |
People of Nueclear
2 people are tracked at Nueclear (2 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership | |
Arokiaswamy Velumani | CEO | Leadership |
Complete people profiles for Nueclear
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Nueclear
Figures of Nueclear Healthcare Limited, the primary company behind Nueclear, for FY 2026. Revenue was ₹49.49 Cr (-3% year on year). Net profit was ₹6.16 Cr (12% margin). EBITDA was ₹11.03 Cr (22% margin). Revenue has grown at a compounded annual rate of +4% over three years and +17% over five years.
- ₹49.49 CrRevenue · FY 2026 · -3% YoY
- ₹6.16 CrNet profit · 12% margin
- ₹11.03 CrEBITDA · 22% margin
- ₹11.11 CrPaid-up capital
- +4%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nueclear Healthcare Limited are on its company page.
Detailed financial statements for Nueclear
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Nueclear
2 dated milestones of Nueclear, from founding to its latest funding, stage changes and deals.
- Founded Nueclear is founded.
- Funding First funding round of $4.0M.
Web traffic of Nueclear
The website of Nueclear (nueclear.com) receives about 7.1K visits a month.
- Monthly visits7.1K
▲ 246.8% vs previous month
Websites whose visitors overlap most with Nueclear. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sldiagnostics.com | 100% | View details | |||
vistaimaging.in | vistaimaging.in | 100% | #6,850,355 | – | |
| tesladiagnostics.com | 95% | 1.5K | #10,222,879 | View details |
Top companies in Diagnostics Laboratories
3 companies that operate in the same segment as Nueclear (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Diagnostic testing centers for pathology and health screenings are operated. | 1996 | Mumbai, Maharashtra, India | USD 63.59 M | USD 90.17 M | 1,979 | |
Chain of pathology and radiology labs | 1949 | Gurugram, Haryana, India | USD 13.9 M | USD 294.49 M | 5,310 | |
Home-based diagnostic tests are booked via an online platform. | 2018 | Noida, Uttar Pradesh, India | USD 116.42 M | USD 41.86 M | 2,308 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nueclear
Complete news archive for Nueclear
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nueclear
Nueclear was founded in 2013.
Nueclear is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Rahul Guha is the CEO of Nueclear, as recorded in our data.
Nueclear is a funded company, having raised a total of $4M across 1 funding round to date. The company's 1st funding round was a Series A of $4M, raised on Jan 2013.
The primary company behind Nueclear, Nueclear Healthcare Limited, reported revenue of ₹49.49 Cr for FY 2026, down 3% year on year.
Founded in 2013 in Mumbai, India, Nueclear operates as a network of diagnostic centers focused on cancer imaging. Services encompass various PET-CT scans, plain and contrast CT scans, and production of required radioactive biomarkers using advanced technologies. Appointments are scheduled, reports delivered via in-person, email, or courier methods, and payments processed online. Operations emphasize early detection and monitoring through affordable solutions in the healthcare sector.
Nueclear offers PET-CT Scan and CT Scan.
Nueclear has 1 investor. Key investors include Norwest Venture Partners.
Nueclear operates through Nueclear Healthcare Limited.
The legal entities of Nueclear currently have 7 directors, including Rahul Franklin Guha, Ravi Shankar Tiwari, Nishant Amilal Shah and others.